banner

Posts tagged as: diabetes news back to homepage

ALR Technologies Adds Board Members, Readies for Commercialization ALR Technologies Adds Board Members, Readies for Commercialization(0)

Following news from last week that it has completed the development phase for its Health-e-Connect system, a universal platform for remote monitoring of chronic disease, ALR Technologies (OTCBB: ALRT) said this morning that it has added new members to its Board of Directors.  The company also reported that board member and VP of Technology Jaroslav V. Tichy, PhD, will be retiring from those positions and now serve as a consultant to ALRT.  Tichy, who is now 71 years old, played a key role Read More

ALR Technologies Nears Commercialization of Diabetes Management Systems ALR Technologies Nears Commercialization of Diabetes Management Systems(0)

Following an announcement earlier this month providing shareholders with an update on the commercial launch of its Health-e-Connect system for remote monitoring and chronic disease management, ALR Technologies released news today further detailing its systems, including a unique universal cable.  As part of the introduction of the universal cable, Read More

ALRT Gears Up for Commercialization of Diabetes Management System ALRT Gears Up for Commercialization of Diabetes Management System(0)

ALR Technologies Updates Shareholders on Commercial Launch of Diabetes Management System

ALR Technologies Inc. (OTCBB: ALRT) (the “Company”), a health information technology company, is pleased to provide shareholders with an update for its FDA-cleared Health-e-Connect System (“the System”) for remote monitoring and chronic disease management. Read More

New Technologies to Contain Waste in Diabetes Test Supplies(0)

Opportunity for Medicare to Reduce Millions in Costs
At the same time that the federal government seeks to cut Medicare spending, awareness is growing about a fraudulent practice around diabetes test strips that is running up program costs and putting the health of patients at risk. Read More



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.